Literature DB >> 10875321

Bone mineral density in patients with type 1 diabetes mellitus.

A Rozadilla1, J M Nolla, E Montaña, J Fiter, C Gómez-Vaquero, J Soler, D Roig-Escofet.   

Abstract

Although osteopenia is often reported as a complication of type 1 diabetes mellitus, its frequency and severity remain unclear, and studies of bone mineral density in type 1 diabetics have yielded conflicting results. We measured bone mineral density at the lumbar spine and femoral neck in 88 Spanish adults with type 1 diabetes mellitus responsible for moderately severe complications. Mean age (+/- SD) was 28.9 +/- 8.8 years, and mean disease duration was 11.2 +/- 6.4 years. As compared to normal Spanish adults, bone mineral density was decreased in the patients at the lumbar spine (Z-score, -0.32 +/- 1.08; P < 0.001) but not at the femoral neck (Z-score, -0.21 +/- 1.03; P non-significant). The magnitude of bone loss in the diabetics was small (T-score, -0.38 +/- 1.13 at the lumbar spine and -0.37 +/- 1.08 at the femoral neck). Only three patients met WHO criteria for osteoporosis at one or both measurement sites. Patients with retinopathy (n = 37) had lower lumbar spine bone mineral density values than patients without retinopathy; however, this difference was no longer present after adjustment for age and disease duration. Bone mineral density values were similar in patients with (n = 13) and without microalbuminuria. Our findings suggest that bone loss is not a major problem in younger type 1 diabetics with short disease durations and no severe diabetic complications.

Entities:  

Mesh:

Year:  2000        PMID: 10875321

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  9 in total

Review 1.  Epidemiology of Skeletal Health in Type 1 Diabetes.

Authors:  David R Weber; George Schwartz
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

Review 2.  Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis.

Authors:  P Vestergaard
Journal:  Osteoporos Int       Date:  2006-10-27       Impact factor: 4.507

Review 3.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.

Authors:  Kathryn M Thrailkill; Charles K Lumpkin; R Clay Bunn; Stephen F Kemp; John L Fowlkes
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11       Impact factor: 4.310

Review 4.  Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice.

Authors:  V V Zhukouskaya; C Eller-Vainicher; A P Shepelkevich; Y Dydyshko; E Cairoli; I Chiodini
Journal:  J Endocrinol Invest       Date:  2015-04-12       Impact factor: 4.256

5.  Poor glycemic control is associated with low BMD detected in premenopausal women with type 1 diabetes.

Authors:  K K Danielson; M E Elliott; T LeCaire; N Binkley; M Palta
Journal:  Osteoporos Int       Date:  2008-10-02       Impact factor: 4.507

6.  Osteoporosis in men with diabetes mellitus.

Authors:  Claire Issa; Mira S Zantout; Sami T Azar
Journal:  J Osteoporos       Date:  2011-06-15

7.  Low bone mineral density and its predictors in type 1 diabetic patients evaluated by the classic statistics and artificial neural network analysis.

Authors:  Cristina Eller-Vainicher; Volha V Zhukouskaya; Yury V Tolkachev; Sergei S Koritko; Elisa Cairoli; Enzo Grossi; Paolo Beck-Peccoz; Iacopo Chiodini; Alla P Shepelkevich
Journal:  Diabetes Care       Date:  2011-08-18       Impact factor: 19.112

8.  Relation between the insulin lowering rate and changes in bone mineral density: Analysis among subtypes of type 1 diabetes mellitus.

Authors:  Masaki Suzuki; Shin Urai; Hidenori Fukuoka; Yushi Hirota; Masaaki Yamamoto; Yuko Okada; Naoki Yamamoto; Hiroki Shichi; Yasunori Fujita; Keitaro Kanie; Genzo Iguchi; Yutaka Takahashi; Wataru Ogawa
Journal:  J Diabetes Investig       Date:  2022-05-31       Impact factor: 3.681

9.  Prevalence of morphometric vertebral fractures in patients with type 1 diabetes.

Authors:  Volha V Zhukouskaya; Cristina Eller-Vainicher; Volha V Vadzianava; Alla P Shepelkevich; Irina V Zhurava; Galina G Korolenko; Olga B Salko; Elisa Cairoli; Paolo Beck-Peccoz; Iacopo Chiodini
Journal:  Diabetes Care       Date:  2013-01-22       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.